⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

September 16, 2020Neurology Neuroimmunology & NeuroinflammationOpen Access

Bickerstaff brainstem encephalitis with or without anti-GQ1b antibody

Keisuke Yoshikawa Motoi Kuwahara Miyuki Morikawa Susumu Kusunoki

View Full Paper

Ask AI

Bookmark

Share

Abstract

BBE with anti-GQ1b antibody has homogeneous features. IVIG is the treatment used prevalently for BBE with anti-GQ1b antibody in Japan.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Yoshikawa et al. (2020) studied this question.

synapsesocial.com/papers/69d945ddf20ef2633068465d https://doi.org/10.1212/nxi.0000000000000889

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Nationwide survey of patients in Japan with Bickerstaff brainstem encephalitis: epidemiological and clinical characteristicsSurvey · 2012 · 108 citations
2<i>N</i>‐acetylgalactosaminyl GD1a is a target molecule for serum antibody in Guillain‐Barré syndromeOriginal Research · 1994 · 180 citations
3Antibodies to heteromeric glycolipid complexes in multifocal motor neuropathyOriginal Research · 2012 · 60 citations
4Antibodies to Heteromeric Glycolipid Complexes in Guillain-Barré SyndromeOriginal Research · 2013 · 77 citations
5Guillain-Barré syndrome in northern China Relationship to <i>Campylobacter jejuni</i> infection and anti-glycolipid antibodiesCohort Study · 1995 · 765 citations

Bickerstaff’s brainstem encephalitis: clinical features of 62 cases and a subgroup associated with Guillain–Barré syndrome2003
Anti-GQ1b ganglioside positive Miller Fisher syndrome – evidence of paranodal pathology on nerve biopsy2014
Special sensory ataxia in Miller Fisher syndrome detected by postural body sway analysis1999
Application of Optic Neuritis Diagnostic Criteria in Autoimmune Paraneoplastic CRMP5 Optic Neuropathy and Development of the “CRMP” ScoreNeurology Neuroimmunology & Neuroinflammation · 2026
A 35-Year-Old Woman With Multiple Sclerosis and a New Atypical Thalamic LesionNeurology Neuroimmunology & Neuroinflammation · 2026

More from Neurology Neuroimmunology & Neuroinflammation

More from Kindai University